EFA
RPID icon

Evernest Financial Advisors’s Rapid Micro Biosystems RPID Stock Holding History

Evernest Financial Advisors’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$875K Buy
506,000
+73,490
+17% +$155K 0.18% 87
2026
Q1 		$1.02M Buy
432,510
+307,510
+246% +$1.13M 0.21% 72
2025
Q4 		$469K Sell
125,000
-75,234
-38% -$261K 0.1% 120
2025
Q3 		$669K Buy
200,234
+156,234
+355% +$494K 0.19% 98
2025
Q2 		$152K Sell
44,000
-87,265
-66% -$253K 0.05% 166
2025
Q1 		$347K Buy
+131,265
New +$299K 0.12% 121

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Evernest Financial Advisors's RPID Position: Q2 2026 in Review

Evernest Financial Advisors increased its Rapid Micro Biosystems (RPID) stake by 17% in Q2 2026, buying an estimated $155K and bringing the position to 506,000 shares worth $875K. The position accounts for 0.18% of the portfolio, ranked #87.

Evernest Financial Advisors first reported a position in RPID in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.02M in Q1 2026. 34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • Evernest Financial Advisors held 506,000 shares of Rapid Micro Biosystems worth $875K as of Q2 2026.
  • Evernest Financial Advisors bought 73,490 Rapid Micro Biosystems shares in Q2 2026, an estimated $155K.
  • Rapid Micro Biosystems made up 0.18% of Evernest Financial Advisors's portfolio in Q2 2026, its #87 holding.
  • Evernest Financial Advisors first reported a position in Rapid Micro Biosystems in Q1 2025 and has held it in 6 quarters since.
  • Evernest Financial Advisors's Rapid Micro Biosystems position peaked at $1.02M in Q1 2026.
  • 34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Evernest Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.